Neumora Therapeutics NMRA
NASDAQ NMRA
$0.38 -0.03 (-6.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Income Taxes Paid (2024 - 2026)

Updated

Analysis

Neumora Therapeutics (NMRA) Income Taxes Paid (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes Paid (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 398.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 2.58 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 3.47 Bn
10 Neumora Therapeutics 69.36 Mn -548.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 30,000.00
Dec 31, 2025 323,000.00
Sep 30, 2024 473,000.00
API Access

Neumora Therapeutics Income Taxes Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-taxes-paid&ticker=NMRA&period=max&api_key=YOUR_API_KEY